遗传性与医源性转甲状腺素蛋白淀粉样神经病的早期皮肤去神经支配
该研究评估了遗传性转甲状腺素蛋白(TTR)淀粉样变患者、无症状突变携带者、医源性TTR淀粉样变患者及健康志愿者的表皮内神经纤维密度(IENFD)与临床指标。结果显示各患者组及症状前携带者的IENFD均显著低于健康志愿者,且IENFD与病程及多项周围神经病变参数相关,提示IENFD可能有助于早期诊断并作为生物标志物。
要点
- 遗传性TTR淀粉样变患者及医源性TTR淀粉样变患者IENFD均显著降低。
- 症状前V30M突变携带者已出现皮肤去神经支配。
- IENFD与病程及感觉神经功能参数相关,可能作为早期诊断标志物。
核心结论
- 遗传性与医源性TTR淀粉样变患者可能在症状前阶段即出现皮肤去神经支配,IENFD或有助于早期诊断并作为临床试验生物标志物。
研究设计与样本
- 研究纳入32例遗传性TTR淀粉样变患者、11例无症状突变携带者、6例医源性TTR淀粉样变患者和23名健康志愿者,评估IENFD与临床发现。
主要发现
- V30M突变患者IENFD为1.9 ± 2.1每1 mm,非V30M突变患者为5.8 ± 3.2每1 mm,医源性TTR淀粉样变患者为3.5 ± 1.8每1 mm,均低于健康志愿者的11.8 ± 3.2每1 mm(p < 0.01)。
- 症状前V30M突变携带者IENFD为5.0 ± 2.2每1 mm,已出现皮肤去神经支配。
- IENFD与病程(ρ = -0.533, p = 0.002)、熊本临床评分中感觉障碍(ρ = -0.575, p = 0.001)、热痛检测阈值(ρ = -0.704, p < 0.001)及腓肠感觉神经动作电位(ρ = 0.481, p = 0.005)相关。
- 遗传性与医源性TTR淀粉样变患者的真皮网状层结缔组织和血管中常见TTR淀粉样沉积。
临床怎么用
- 对于疑诊遗传性或医源性TTR淀粉样变患者,可考虑IENFD检测以评估早期皮肤去神经支配。
- 对无症状TTR突变携带者,IENFD可能有助于发现症状前神经病变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To elucidate early skin denervation in hereditary transthyretin (TTR) amyloidosis and iatrogenic TTR amyloidosis. METHODS: We investigated intraepidermal nerve fiber density (IENFD) and clinical findings in 32 patients with hereditary TTR amyloidosis, 11 asymptomatic mutation carriers, 6 patients with iatrogenic TTR amyloidosis, and 23 healthy volunteers. RESULTS: IENFD values were reduced in patients with the V30M mutation (1.9 ± 2.1 per 1 mm), patients with non-V30M mutations (5.8 ± 3.2 per 1 mm), and patients with iatrogenic TTR amyloidosis (3.5 ± 1.8 per 1 mm) compared with healthy volunteers (11.8 ± 3.2 per 1 mm) (p < 0.01). Skin denervation also occurred, even in presymptomatic V30M mutation carriers (5.0 ± 2.2 per 1 mm). The IENFD was correlated with disease duration (ρ = -0.533, p = 0.002) and various peripheral neuropathy parameters such as sensory impairment in the Kumamoto clinical score (ρ = -0.575, p = 0.001), heat-pain detection threshold (ρ = -0.704, p < 0.001), and sural sensory nerve action potential (ρ = 0.481, p = 0.005). TTR amyloid deposits frequently occurred in connective tissues and vessels of the dermal reticular layer in patients with hereditary TTR amyloidosis and those with iatrogenic TTR amyloidosis. CONCLUSIONS: Patients with hereditary TTR amyloidosis and those with iatrogenic TTR amyloidosis may show early skin denervation even in the presymptomatic stage. IENFD may thus be useful for early diagnosis and may serve as a biomarker in clinical trials for hereditary and iatrogenic TTR amyloidosis.
引用
- Masuda T, Ueda M, Suenaga G, et al. Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy. Neurology. 2017. PMID: 28490654. doi:10.1212/WNL.0000000000004016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。